GCP ClinPlus
PrivateLast Round
Series B
Extension
Aug 5, 2025
Total Funding Raised
$14.86M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GCP ClinPlus operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series B Extension round in August 2025.
GCP ClinPlus is a contract research organization (CRO) that provides end-to-end clinical trial services for pharmaceutical, biopharmaceutical, and medical device companies.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Biotechnology, Medical Devices, Compliance
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GCP ClinPlus Comparables
Compare GCP ClinPlus with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quarkmed | 89% | |
| Bestudy (Shanghai) Medical Technology Co., Ltd. | 89% | |
| Hangzhou Tigermed Consulting Co., Ltd. | 86% |
For institutional investors. Book with your work email.
GCP ClinPlus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Aug 5, 2025 | ||||
| Series B | Jul 1, 2022 | ||||
| Angel | Aug 1, 2010 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 3, 2026
Integrated with Probiocdmo to enhance trial predictability.
- Aug 18, 2025
Selected as CRO partner for OcuMension's anti-VEGF drug, OT-702.
For institutional investors. Book with your work email.
GCP ClinPlus Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GCP ClinPlus's valuation, stock price, and market status.
Is GCP ClinPlus a public or private company?
GCP ClinPlus is a private company.
What is the current stock price of GCP ClinPlus?
GCP ClinPlus is a private company, so its shares have no public market price. Caplight tracks GCP ClinPlus's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GCP ClinPlus worth (valuation)?
Valuation information for GCP ClinPlus is not publicly available.
Can I buy GCP ClinPlus stock?
GCP ClinPlus shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GCP ClinPlus's last funding round?
GCP ClinPlus's most recent funding round was Series B Extension on August 5, 2025.
Who are the main investors in GCP ClinPlus?
Investor information for GCP ClinPlus is not publicly disclosed.
Will GCP ClinPlus IPO soon?
No public IPO plans have been announced for GCP ClinPlus.
How can I track GCP ClinPlus secondary market activity?
Caplight tracks bids, offers, and trades in GCP ClinPlus's shares on secondary markets.